SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.08.2026. Verfasst von Yufei Han und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking Universit…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Ubiquitin Thiolesterase, Membrane Proteins, Scavenger Receptors, Class A. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Innovative Drug Research and Development National Science and Technology Major Project to Xunde Xian; Peking University Medicine plus X Pilot Program-Platform….
Abstract (Originalsprache)
Acute myocardial infarction (MI) is a leading cause of mortality worldwide. Although reperfusion restores coronary blood flow, it paradoxically induces secondary injury that limits therapeutic benefits, and effective interventions for myocardial ischemia/reperfusion injury (MI/RI) remain lacking. Here, we identify scavenger receptor class A member 3 (SR‐A3) as a previously unrecognized cardioprotective factor that plays a central regulatory role in ischemic injury. SR‐A3 was significantly downregulated in myocardial tissues from MI/RI patients. Global or cardiomyocyte‐specific deletion of SR‐A3 exacerbated MI/RI‐induced cardiac damage, whereas AAV9‐mediated overexpression alleviated myocardial injury and improved cardiac function. Notably, SR‐A3 expression in cardiomyocytes underwent the most dramatic reduction upon I/R stress, underscoring its critical role in the injured myocardium. Mechanistically, SR‐A3 interacts with ubiquitin‐specific peptidase 18 (USP18) to suppress interferon‐stimulated gene 15 (ISG15)‐dependent ISGylation, thereby negatively regulating activation of the STING signaling pathway and its downstream innate immune inflammatory cascades. Treatment with Selonsertib, an ASK1 inhibitor that increased USP18 abundance in our MI/RI model, recapitulated the cardioprotective effects, highlighting the translational potential of targeting this signaling axis. Collectively, our findings uncover a novel SR‐A3/USP18/ISG15/STING regulatory pathway governing innate immune activation in MI/RI and position SR‐A3 as a promising therapeutic target for ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, Beijing, China.
- Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
- National Clinical Research Center for Cardiovascular Diseases, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Shepton High School, Plano, Texas, USA.
- Department of Cardiology, Peking University First Hospital, Beijing, China.
- Research Center for Cardiopulmonary Rehabilitation, University of Health and Rehabilitation Sciences Qingdao Hospital (Qingdao Municipal Hospital), School of Health and Life Sciences, University of Health and Rehabilita…
ORCID-Profile: Yufei Han, Kaikai Lu, Xianqin Shen, Yuhui Wang, Erdan Dong, Xunde Xian
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Innovative Drug Research and Development National Science and Technology Major Project to Xunde Xian; Peking University Medicine plus X Pilot Program-Platform…
- CAMS Innovation Fund for Medical Sciences
- NSFC
- China Postdoctoral Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Han, Y., Miao, G., Zhao, Y., Du, Z., Lu, K., Xiao, C., Xian, A., Duanmu, J., Zhou, Z., Chen, J., Zhang, L., Zhai, C., Xu, Y., Li, Z., Shen, X., Shi, S., Chen, J., Mei, S., Fang, Y., …, & Xian, X. (2026). SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury. Advanced Science, 13(62). https://doi.org/10.1002/advs.77196
Vancouver
Han Y, Miao G, Zhao Y, Du Z, Lu K, Xiao C, et al. SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury. Advanced Science. 2026;13(62). doi:10.1002/advs.77196
BibTeX
@article{Han2026,
author = {Han, Yufei and Miao, Guolin and Zhao, Yinqi and Du, Zhiyong and Lu, Kaikai and Xiao, Changqi and Xian, Aiden and Duanmu, Jiaxin and Zhou, Zihao and Chen, Jinxuan and Zhang, Lianxin and Zhai, Chao and Xu, Yitong and Li, Zhaoling and Shen, Xianqin and Shi, Sijing and Chen, Jingxuan and Mei, Si and Fang, Yuan and Zheng, Liwen and Zhang, Ling and Wang, Yuhui and Huang, Wei and Dong, Erdan and Xian, Xunde},
title = {SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77196}
}
EUVIMED